Capricor Therapeutics Price to Sales Ratio 2010-2023 | CAPR
Historical PS ratio values for Capricor Therapeutics (CAPR) over the last 10 years. The current P/S ratio for Capricor Therapeutics as of April 23, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Capricor Therapeutics P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-04-23 | 4.82 | 5.00 | |
| 2023-12-31 | 4.89 | $0.96 | 5.07 |
| 2023-09-30 | 3.42 | $0.55 | 6.20 |
| 2023-06-30 | 4.78 | $0.38 | 12.67 |
| 2023-03-31 | 4.22 | $0.22 | 18.96 |
| 2022-12-31 | 3.86 | $0.10 | 37.03 |
| 2022-09-30 | 6.00 | $0.07 | 92.10 |
| 2022-06-30 | 3.49 | 0 | 0.00 |
| 2022-03-31 | 3.43 | $0.01 | 0.00 |
| 2021-12-31 | 2.93 | $0.01 | 272.22 |
| 2021-09-30 | 4.02 | $0.01 | 277.71 |
| 2021-06-30 | 5.13 | $0.02 | 334.66 |
| 2021-03-31 | 4.68 | $0.01 | 0.00 |
| 2020-12-31 | 3.43 | $0.03 | 98.40 |
| 2020-09-30 | 5.25 | $0.09 | 57.70 |
| 2020-06-30 | 4.60 | $0.13 | 35.92 |
| 2020-03-31 | 1.20 | $0.24 | 4.93 |
| 2019-12-31 | 1.28 | $0.29 | 4.49 |
| 2019-09-30 | 3.70 | $0.45 | 8.30 |
| 2019-06-30 | 3.32 | $0.48 | 6.92 |
| 2019-03-31 | 4.66 | $0.50 | 9.33 |
| 2018-12-31 | 4.10 | $0.58 | 7.07 |
| 2018-09-30 | 10.50 | $0.54 | 19.55 |
| 2018-06-30 | 13.40 | $0.60 | 22.35 |
| 2018-03-31 | 13.60 | $0.91 | 14.94 |
| 2017-12-31 | 15.80 | $1.17 | 13.46 |
| 2017-09-30 | 30.30 | $1.48 | 20.41 |
| 2017-06-30 | 8.30 | $1.76 | 4.72 |
| 2017-03-31 | 33.80 | $1.94 | 17.44 |
| 2016-12-31 | 26.60 | $2.26 | 11.76 |
| 2016-09-30 | 32.43 | $2.48 | 13.08 |
| 2016-06-30 | 39.50 | $2.88 | 13.71 |
| 2016-03-31 | 25.40 | $3.05 | 8.34 |
| 2015-12-31 | 30.74 | $3.51 | 8.75 |
| 2015-09-30 | 40.50 | $4.01 | 10.11 |
| 2015-06-30 | 50.50 | $4.31 | 11.72 |
| 2015-03-31 | 86.20 | $4.40 | 19.57 |
| 2014-12-31 | 37.50 | $4.09 | 9.16 |
| 2014-09-30 | 38.50 | $2.89 | 13.30 |
| 2014-06-30 | 44.00 | $1.86 | 23.66 |
| 2014-03-31 | 85.00 | $1.15 | 73.79 |
| 2013-12-31 | 32.50 | $0.49 | 66.85 |
| 2013-09-30 | 25.00 | $2.20 | 11.37 |
| 2013-06-30 | 25.00 | $2.12 | 11.79 |
| 2013-03-31 | 50.00 | $1.94 | 25.80 |
| 2012-12-31 | 25.00 | $4.17 | 5.99 |
| 2012-09-30 | 55.00 | $5.08 | 10.83 |
| 2012-06-30 | 50.00 | $15.32 | 3.26 |
| 2012-03-31 | 250.00 | $20.25 | 12.35 |
| 2011-12-31 | 275.00 | $17.79 | 15.46 |
| 2011-09-30 | 315.00 | $15.17 | 20.77 |
| 2011-06-30 | 390.00 | $4.93 | 79.13 |
| 2011-03-31 | 410.00 | 0 | 0.00 |
| 2010-12-31 | 310.00 | 0 | 0.00 |
| 2010-09-30 | 315.00 | 0 | 0.00 |
| 2010-06-30 | 165.00 | 0 | 0.00 |
| 2010-03-31 | 490.00 | 0 | 0.00 |
| 2009-12-31 | 605.00 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.156B | $0.025B |
| Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $185.786B | 24.39 |
| Stryker (SYK) | United States | $124.672B | 30.91 |
| Medtronic (MDT) | Ireland | $106.983B | 15.15 |
| Boston Scientific (BSX) | United States | $99.792B | 33.18 |
| EssilorLuxottica (ESLOY) | France | $98.590B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.472B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.173B | 29.86 |
| ResMed (RMD) | United States | $26.527B | 26.52 |
| Terumo (TRUMY) | Japan | $25.252B | 35.66 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.816B | 15.98 |
| Baxter (BAX) | United States | $20.516B | 14.96 |
| Koninklijke Philips (PHG) | Netherlands | $19.139B | 15.27 |
| Insulet (PODD) | United States | $11.513B | 60.45 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.649B | 0.00 |
| Demant (WILYY) | Denmark | $9.853B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.989B | 23.80 |
| BellRing Brands (BRBR) | United States | $7.214B | 38.79 |
| Lantheus Holdings (LNTH) | United States | $4.324B | 11.16 |
| Haemonetics (HAE) | United States | $4.247B | 21.72 |
| Perrigo (PRGO) | Ireland | $4.074B | 11.65 |
| GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
| Prestige Consumer Healthcare (PBH) | United States | $3.466B | 16.39 |
| Envista Holdings (NVST) | United States | $3.456B | 13.14 |
| QuidelOrtho (QDEL) | United States | $2.614B | 9.49 |
| Neogen (NEOG) | United States | $2.552B | 24.54 |
| Green Thumb Industries (GTBIF) | United States | $2.526B | 80.07 |
| ICU Medical (ICUI) | United States | $2.348B | 17.52 |
| TG Therapeutics (TGTX) | United States | $2.179B | 705.00 |
| Owens & Minor (OMI) | United States | $1.856B | 17.82 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.853B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.698B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.652B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.444B | 44.98 |
| InMode (INMD) | Israel | $1.439B | 7.45 |
| LeMaitre Vascular (LMAT) | United States | $1.409B | 46.50 |
| AdaptHealth (AHCO) | United States | $1.276B | 9.60 |
| Warby Parker (WRBY) | United States | $1.218B | 0.00 |
| AtriCure (ATRC) | United States | $1.099B | 0.00 |
| MacroGenics (MGNX) | United States | $0.964B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.761B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.715B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.693B | 14.97 |
| Cresco Labs (CRLBF) | United States | $0.684B | 0.00 |
| Evolus (EOLS) | United States | $0.679B | 0.00 |
| Quanterix (QTRX) | United States | $0.623B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| Jin Medical (ZJYL) | China | $0.532B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.529B | 11.45 |
| PetIQ (PETQ) | United States | $0.486B | 18.14 |
| TerrAscend (TSNDF) | Canada | $0.475B | 0.00 |
| ZimVie (ZIMV) | United States | $0.422B | 25.82 |
| Biote (BTMD) | United States | $0.414B | 3.94 |
| OraSure Technologies (OSUR) | United States | $0.409B | 6.77 |
| Surmodics (SRDX) | United States | $0.361B | 39.06 |
| Zynex (ZYXI) | United States | $0.358B | 41.26 |
| Aurora Cannabis (ACB) | Canada | $0.343B | 0.00 |
| Cerus (CERS) | United States | $0.306B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.304B | 30.15 |
| Sanara MedTech (SMTI) | United States | $0.284B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.263B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.245B | 14.91 |
| Organigram Holdings (OGI) | Canada | $0.196B | 0.00 |
| Veru (VERU) | United States | $0.186B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.183B | 0.00 |
| Omeros (OMER) | United States | $0.178B | 0.00 |
| High Tide (HITI) | Canada | $0.171B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.160B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.133B | 66.92 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.77 |
| Jushi Holdings (JUSHF) | United States | $0.127B | 0.00 |
| InterCure (INCR) | Israel | $0.115B | 19.46 |
| Cellectar Biosciences (CLRB) | United States | $0.103B | 0.00 |
| Fonar (FONR) | United States | $0.103B | 8.80 |
| MariMed (MRMD) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.091B | 0.00 |
| Chimerix (CMRX) | United States | $0.082B | 0.00 |
| Brainsway (BWAY) | Israel | $0.079B | 0.00 |
| Safety Shot (SHOT) | United States | $0.077B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.065B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Apyx Medical (APYX) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Bright Green (BGXX) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.52 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.73 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.001B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |